Save Comparison | ![]() ContraFect ContraFect is a biotechnology company focused on developing treatments for drug-resistant, life-threatening infectious diseases. | ![]() TxCell TxCell develops cellular immunotherapy platforms based on antigen-specific regulatory T cells. | ![]() Bioz Bioz is a disruptive startup at the intersection of information technology and scientific research | |
Founding Date | Founding Date 2008 | Founding Date 1998 | Founding Date 2001 | Founding Date 2013 |
Type | Type Public | Type Public | Type Subsidiary | Type Private |
Tags | ||||
Locations | Locations Yonkers, US HQ | Locations Cambridge, GB HQ Hangzhou Shi, CN Shanghai, CN Hong Kong, HK Tokyo, JP Branford, US Burlingame, US see more | Locations Valbonne, FR HQ | Locations Palo Alto, US HQ |
Employees | Employees 2420% increase | Employees 1,49229% increase | Employees 21 | Employees 244% decrease |
Valuation ($) | Valuation ($) 148.5 m | Valuation ($) 5.3 b | Valuation ($) N/A | Valuation ($) N/A |
Twitter followers | Twitter followers N/A | Twitter followers 6.8 k | Twitter followers 460 | Twitter followers 1.1 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 35 | Number of tweets (last 30 days) 2 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 4.4 | Average likes per tweet (last 30 days) 0.5 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 50% | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 293443 | Alexa Website Rank 353947 | Alexa Website Rank N/A | Alexa Website Rank 383129 |
Employee Rating | Employee Rating 2.5 | Employee Rating 4.6 | Employee Rating 1 | Employee Rating 4 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) £260m (FY, 2020) | Revenue (est.) €2.2m (FY, 2017) | Revenue (est.) N/A |
Net income | Net income ($12.8m) (FY, 2019) | Net income £12.5m (FY, 2020) | Net income (€10.9m) (FY, 2017) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 78.8m | Total funding raised $ 71.6m | Total funding raised $ 3m |
Abcam is a life sciences company that identifies and develops biological reagents and tools.
View companyTxCell develops cellular immunotherapy platforms based on antigen-specific regulatory T cells.
View companyBioz is a disruptive startup at the intersection of information technology and scientific research
View company